Campaign targets drug maker price hikes

The Campaign for Sustainable Rx Pricing, for which AHA is a founding member, today launched and urging drug companies to suspend their “traditional” summer price hikes, which last year averaged 13%, saying the industry is thriving while Americans are struggling financially.
“Before COVID-19, more than 58 million Americans struggled to afford their prescription drugs and now the economic impact of the pandemic has left millions more American workers, families and seniors struggling just to stay afloat,” CSRxP Executive Director Lauren Aronson. “Too many Americans were already unable to afford their medications and resorting to dangerous measures like rationing — before the historic economic uncertainty of the current crisis.”
Related News Articles
Headline
The Department of Health and Human Services May 20 announced it has identified specific pricing targets for pharmaceutical manufacturers to meet to satisfy…
Headline
The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation…
Headline
The White House May 12 released an executive order to reduce prescription drug costs by allowing consumers to make direct purchases from drug manufacturers at…
Headline
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription…
Headline
The Department of Commerce yesterday released notices announcing national security investigations on imports of pharmaceuticals, pharmaceutical ingredients and…
Headline
The AHA Feb. 28 filed a friend-of-the-court brief in the U.S. Court of Appeals for the 4th Circuit, urging the court to affirm a decision by the U.S. District…